Search research articles
Contact Us
Filters
Showing results (31-40 of 58) with videos related to
Page
of 6
Sort By:
AJR. American Journal of Roentgenology
|
September 15, 2021
Prediction of Early Treatment Response in Multiple Myeloma Using MY-RADS Total Burden Score, ADC, and Fat Fraction From Whole-Body MRI: Impact of Anemia on Predictive Performance
Huazheng Dong, Wenyang Huang, Xiaodong Ji, et al.
Blood Science (Baltimore, Md.)
|
January 19, 2024
Sequential treatment escalation improves survival in patients with Waldenstrom macroglobulinemia
Ying Yu, Wenjie Xiong, Tingyu Wang, et al.
Frontiers in Immunology
|
July 24, 2023
Real-world treatment patterns, discontinuation and clinical outcomes in patients with B-cell lymphoproliferative diseases treated with BTK inhibitors in China
Yuting Yan, Rui Lv, Tingyu Wang, et al.
British Journal of Haematology
|
July 30, 2021
Undetectable minimal residual disease is an independent prognostic factor in splenic marginal zone lymphoma
Rui Lyu, Tingyu Wang, Yi Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 7, 2025
Zanubrutinib plus Ixazomib and Dexamethasone in Newly Diagnosed Symptomatic Waldenström Macroglobulinemia: A Phase II Study
Wenjie Xiong, Yuting Yan, Tingyu Wang, et al.
Biochemical Pharmacology
|
February 26, 2026
Cabozantinib inhibits necroptosis by targeting MLKL oligomerization and alleviates psoriasis in vivo
Rui He, Yanzhen Li, Yu Sun, et al.
Cancer Medicine
|
February 13, 2024
Gemcitabine-based conditioning compared to BEAM/BEAC conditioning prior to autologous stem cell transplantation for non-Hodgkin lymphoma: No difference in outcomes
Huimin Liu, Hesong Zou, Dandan Shan, et al.
Magnetic Resonance Imaging
|
October 16, 2025
Total tumor apparent diffusion coefficient histogram analysis of whole-body DWI-MRI for prognostic stratification in patients with R-ISS stage II multiple myeloma
Junde Zhou, Qin Wang, Yanting Liu, et al.
Chinese Medical Journal
|
September 17, 2025
Long-term outcomes of CNCT19 chimeric antigen receptor T-cell therapy in relapsed or refractory aggressive B-cell lymphoma
Wei Liu, Ting Xie, Zhuoxin Zhang, et al.
Journal for Immunotherapy of Cancer
|
March 5, 2024
Dynamic monitoring of circulating tumor DNA reveals outcomes and genomic alterations in patients with relapsed or refractory large B-cell lymphoma undergoing CAR T-cell therapy
Hesong Zou, Wei Liu, Xiaojuan Wang, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 58) with videos related to
Sort By:
Page
of 6
AJR. American Journal of Roentgenology
|
September 15, 2021
Prediction of Early Treatment Response in Multiple Myeloma Using MY-RADS Total Burden Score, ADC, and Fat Fraction From Whole-Body MRI: Impact of Anemia on Predictive Performance
Huazheng Dong, Wenyang Huang, Xiaodong Ji, et al.
Blood Science (Baltimore, Md.)
|
January 19, 2024
Sequential treatment escalation improves survival in patients with Waldenstrom macroglobulinemia
Ying Yu, Wenjie Xiong, Tingyu Wang, et al.
Frontiers in Immunology
|
July 24, 2023
Real-world treatment patterns, discontinuation and clinical outcomes in patients with B-cell lymphoproliferative diseases treated with BTK inhibitors in China
Yuting Yan, Rui Lv, Tingyu Wang, et al.
British Journal of Haematology
|
July 30, 2021
Undetectable minimal residual disease is an independent prognostic factor in splenic marginal zone lymphoma
Rui Lyu, Tingyu Wang, Yi Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 7, 2025
Zanubrutinib plus Ixazomib and Dexamethasone in Newly Diagnosed Symptomatic Waldenström Macroglobulinemia: A Phase II Study
Wenjie Xiong, Yuting Yan, Tingyu Wang, et al.
Biochemical Pharmacology
|
February 26, 2026
Cabozantinib inhibits necroptosis by targeting MLKL oligomerization and alleviates psoriasis in vivo
Rui He, Yanzhen Li, Yu Sun, et al.
Cancer Medicine
|
February 13, 2024
Gemcitabine-based conditioning compared to BEAM/BEAC conditioning prior to autologous stem cell transplantation for non-Hodgkin lymphoma: No difference in outcomes
Huimin Liu, Hesong Zou, Dandan Shan, et al.
Magnetic Resonance Imaging
|
October 16, 2025
Total tumor apparent diffusion coefficient histogram analysis of whole-body DWI-MRI for prognostic stratification in patients with R-ISS stage II multiple myeloma
Junde Zhou, Qin Wang, Yanting Liu, et al.
Chinese Medical Journal
|
September 17, 2025
Long-term outcomes of CNCT19 chimeric antigen receptor T-cell therapy in relapsed or refractory aggressive B-cell lymphoma
Wei Liu, Ting Xie, Zhuoxin Zhang, et al.
Journal for Immunotherapy of Cancer
|
March 5, 2024
Dynamic monitoring of circulating tumor DNA reveals outcomes and genomic alterations in patients with relapsed or refractory large B-cell lymphoma undergoing CAR T-cell therapy
Hesong Zou, Wei Liu, Xiaojuan Wang, et al.
Page
of 6